Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Total Debt (2020 - 2024)

Intelligent Bio Solutions has reported Total Debt over the past 5 years, most recently at $150426.0 for Q1 2024.

  • For Q1 2024, Total Debt fell 68.05% year-over-year to $150426.0; the TTM value through Mar 2024 reached $150426.0, down 68.05%, while the annual FY2023 figure was $402862.0, 85.8% down from the prior year.
  • Total Debt for Q1 2024 was $150426.0 at Intelligent Bio Solutions, down from $230969.0 in the prior quarter.
  • Over five years, Total Debt peaked at $5.1 million in Q2 2020 and troughed at $9536.0 in Q4 2021.
  • A 5-year average of $829892.5 and a median of $354548.0 in 2023 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: plummeted 99.74% in 2021 and later surged 21190.87% in 2022.
  • Year by year, Total Debt stood at $431621.0 in 2020, then crashed by 97.79% to $9536.0 in 2021, then surged by 5220.92% to $507403.0 in 2022, then plummeted by 54.48% to $230969.0 in 2023, then crashed by 34.87% to $150426.0 in 2024.
  • Business Quant data shows Total Debt for INBS at $150426.0 in Q1 2024, $230969.0 in Q4 2023, and $306234.0 in Q3 2023.